Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 21, 2023

BUY
$50.24 - $80.48 $389,360 - $623,720
7,750 Added 96.88%
15,750 $1.12 Million
Q2 2022

Aug 15, 2022

BUY
$50.24 - $80.48 $235,826 - $377,773
4,694 Added 42.46%
15,750 $1.12 Million
Q1 2022

Sep 21, 2023

SELL
$57.98 - $93.5 $1.02 Million - $1.65 Million
-17,672 Reduced 68.84%
8,000 $639,000
Q1 2022

May 16, 2022

SELL
$57.98 - $93.5 $960,206 - $1.55 Million
-16,561 Reduced 59.97%
11,056 $660,000
Q4 2021

Sep 21, 2023

BUY
$88.02 - $127.79 $2.26 Million - $3.28 Million
25,672 New
25,672 $2.34 Million
Q4 2021

Feb 14, 2022

BUY
$88.02 - $127.79 $2.43 Million - $3.53 Million
27,617 New
27,617 $2.42 Million
Q3 2020

Nov 13, 2020

SELL
$45.65 - $61.81 $142,062 - $192,352
-3,112 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$29.15 - $61.54 $90,714 - $191,512
3,112 New
3,112 $192,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.15B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.